Opioid peptide deltorphin II simulates the cardioprotective effect of ischemic preconditioning: role of δ₂-opioid receptors, protein kinase C, and K(ATP) channels.
L N Maslov, E I Barzakh, A V Krylatov, G A Chernysheva, T Krieg, N V Solenkova, A Yu Lishmanov, S Yu Cybulnikov, Y Zhang
Index: Bull. Exp. Biol. Med. 149(5) , 591-3, (2010)
Full Text: HTML
Abstract
The cardioprotective properties of a δ₂-opioid receptor agonist deltorphin II were studied in rats with coronary occlusion and reperfusion. Opioid receptor ligands and inhibitors (glybenclamide, chelerythrine, and 5-hydroxydecanoate) were injected intravenously before ischemia and reperfusion. A δ₂-opioid receptor agonist deltorphin II significantly decreased the infarction zone/risk zone index. This effect was abolished by naltrexone, naloxone methiodide, and δ₂-opioid receptor antagonist naltriben, but not by a δ₁-opioid receptor antagonist BNTX. The infarct-limiting effect of deltorphin II was not observed after inhibition of protein kinase C or blockade of mitochondrial K(ATP) channels.
Related Compounds
Related Articles:
2008-06-01
[Biochim. Biophys. Acta 1778(6) , 1483-92, (2008)]
Delta opioid receptor-mediated analgesia is not altered in preprotachykinin A knockout mice.
2010-12-01
[Eur. J. Neurosci. 32(11) , 1921-9, (2010)]
2009-05-01
[Pharm. Res. 26(5) , 1226-35, (2009)]
2011-08-01
[J. Surg. Res. 169(2) , 267-76, (2011)]
2011-06-01
[Am. J. Physiol. Cell Physiol. 300(6) , C1260-9, (2011)]